Evidence map›Paper›PMID 19264965›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation.

Soji Sebastian, Prethish Sreenivas, Ramkumar Sambasivan, Sirisha Cheedipudi, Prashanth Kandalla, Grace K Pavlath, Jyotsna Dhawan

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Epigenetic control of skeletal muscle atrophy.Cellular & molecular biology letters · 2024
    Review
  6. A HIF-2α-dependentAnnals of translational medicine · 2024
    Article
  7. CanPharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Article
  10. Enhanced secretion of promyogenic exosomes by quiescent muscle cells.Frontiers in cell and developmental biology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Soji SebastianCentre for Cellular and Molecular Biology, Hyderabad, 500 007 India.
Prethish Sreenivas
Ramkumar Sambasivan
Sirisha Cheedipudi
Prashanth Kandalla
Grace K Pavlath
Jyotsna Dhawan
Centre for Cellular and Molecular Biology · INEmory University · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Most cells in adult tissues are nondividing. In skeletal muscle, differentiated myofibers have exited the cell cycle permanently, whereas satellite stem cells withdraw transiently, returning to active proliferation to repair damaged myofibers. We have examined the epigenetic mechanisms operating in conditional quiescence by analyzing the function of a predicted chromatin regulator mixed lineage leukemia 5 (MLL5) in a culture model of reversible arrest. MLL5 is induced in quiescent myoblasts and regulates both the cell cycle and differentiation via a hierarchy of chromatin and transcriptional regulators. Knocking down MLL5 delays entry of quiescent myoblasts into S phase, but hastens S-phase completion. Cyclin A2 (CycA) mRNA is no longer restricted to S phase, but is induced throughout G(0)/G(1), with activation of the cell cycle regulated element (CCRE) in the CycA promoter. Overexpressed MLL5 physically associates with the CCRE and impairs its activity. MLL5 also regulates CycA indirectly: Cux, an activator of CycA promoter and S phase is induced in RNAi cells, and Brm/Brg1, CCRE-binding repressors that promote differentiation are repressed. In knockdown cells, H3K4 methylation at the CCRE is reduced, reflecting quantitative global changes in methylation. MLL5 appears to lack intrinsic histone methyl transferase activity, but regulates expression of histone-modifying enzymes LSD1 and SET7/9, suggesting an indirect mechanism. Finally, expression of muscle regulators Pax7, Myf5, and myogenin is impaired in MLL5 knockdown cells, which are profoundly differentiation defective. Collectively, our results suggest that MLL5 plays an integral role in novel chromatin regulatory mechanisms that suppress inappropriate expression of S-phase-promoting genes and maintain expression of determination genes in quiescent cells.

Indexed as

Cell DifferentiationAnimalsChromosomal Proteins, Non-HistoneCyclin ACyclin A2Drosophila ProteinsG1 PhaseGene Knockdown TechniquesHistone-Lysine N-MethyltransferaseHistonesLysineMethylationMiceMyoblastsProtein BindingRepressor ProteinsCCNA2 protein, mouseChromosomal Proteins, Non-HistoneCyclin ACyclin A2Drosophila ProteinsHistone-Lysine N-MethyltransferaseHistonesLysineMLL5 protein, mouseRepressor ProteinsSWI-SNF-B chromatin-remodeling complexTranscription Factorstrx protein, Drosophila

Identifiers

PMID19264965
PMCPMC2651835
OpenAlexW2043534093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.